![](https://endpts.com/wp-content/uploads/2022/08/woman-spotlight-WIB-women-in-biopharma-RD-nominations-special-report-feature-endpts.jpg)
Who are the women making a mark in biopharma R&D? Nominate them for Endpoints’ 2024 special report
It’s one of our favorite times of the year: You can now nominate someone to be spotlighted in Endpoints News’ annual Women in Biopharma R&D special report.
Last year, we passed the 100 mark on the number of women we have honored. They have changed the game in biopharma R&D in unique ways, whether exploring new uses for mRNA technology, pushing the boundaries of immuno-oncology, or advocating for rare disease patients.
Even though the most recent data suggest women are still underrepresented in the upper ranks of biopharma, the impetus for change appears to be growing. We are heartened and inspired by the networks and groups that have formed over the past few years, where women leaders exchange advice and pull each other up.
For the sixth edition of our special report, we continue to look for big thinkers, scientists, executives and other enterprising women who are breaking barriers in drug development and inspiring the next generation of leaders.
To nominate someone, fill out this form by the end of July 1. Nominations must be submitted via this form, and multiple submissions for the same person do not increase the chances of being selected as a finalist. Please make the nominations personal and please make no self-nominations. Finalists will be notified in August, and stay tuned for the report in October!
For a list of all the wonderful women we have already featured in previous years, follow the links to our reports from 2019, 2020, 2021, 2022 and 2023.
Got questions? Reach out to us directly at amber@endpointsnews.com or nicole@endpointsnews.com. (However, please note that email nominations will not be considered.)